In this episode of Investor Insights, Ken Dropiewski sits down with Joe Biller of 3×5 partners to discuss portfolio companies, investment opportunities, and new technologies in the MedTech + Life Sciences space.
Author: Ken Dropiewski
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
– China Grand Pharma will seek regulatory approvals and commercialize CardioFocus’ innovative catheter ablation technology for pulmonary vein isolation – Pulmonary vein isolation is the gold standard treatment for atrial fibrillation MARLBOROUGH, Mass., June 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), […]
Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff
IRVINE, Calif., June 1, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance. This is the first noninvasive solution that unlocks Acumen HPI software and uses machine learning to alert clinicians of the […]
SoundBite Medical’s Shock Wave Technology Continues to Crack Through Severe Calcium with the Addition of its First US Site
MONTREAL–(BUSINESS WIRE)–SoundBite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced the use of its novel Active Wire 0.014” platform at a first site in the United States in the successful treatment of patients suffering from […]
AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services
MOUNTAIN VIEW, Calif., June 2, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced that it has acquired the independent diagnostic testing facility (IDTF) CardioLabs, a leading monitoring and cardiac diagnostic service provider. The acquisition is a cornerstone of AliveCor’s mission to extend its comprehensive […]
AI triage solution for deadly vascular conditions receives FDA clearance and CE Mark
Avicenna.AI announces the introduction of CINA CHEST, including AI tools for detection and emergency triage of pulmonary embolism and aortic dissection MARSEILLE, France , June 2, 2021 /PRNewswire/ — Medical imaging AI specialist Avicenna.AI today announced that it has received certification in the United States and European Union for CINA CHEST, its new AI solution that leverages […]
Prytime Medical Closes Oversubscribed $6M Inside Funding Round to Fuel Commercialization Growth
The capital will be used to accelerate the commercialization of Prytime Medical’s new line of minimally invasive REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) hemorrhage control products. SAN ANTONIO, June 2, 2021 /PRNewswire/ — Prytime Medical Inc – The REBOA CompanyTM, is a leading innovator and global provider of life saving […]
Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd
STOCKHOLM, June 2, 2021 /PRNewswire/ — Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, a Hong Kong-based biotech investment group, today announced that MCG Technology Group will invest in and collaborate with Betagenon. MCG Technology Group will invest 2M USD in exchange for Betagenon equity. Additionally, both […]
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer
Former chief medical officer of MyoKardia to lead clinical development at Renovacor PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2021 it granted stock options to purchase an aggregate of 49,500 shares of common stock to eight new employees whose employment commenced in May 2021 as a material inducement to […]
Recent
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
Atrium Therapeutics Reports First Quarter 2026 Financial Results
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Popular
- No commented posts yet